When your goal is weight loss , it can feel like an uphill battle
Research Use Disclaimer The compounds distributed by USA PEPTIDE SCIENCES , including the BPC-157, TB-500, GHK-Cu 30mg (Glow Blend) research vials, are designated strictly for laboratory research purposes only
Your healthcare provider can recommend the best option based on your personal health situation
GLP-1 receptor agonists mimic the action of naturally occurring hormones that regulate blood glucose and appetite by: Slowing gastric emptying, promoting feelings of fullness Reducing appetite signals in the brains hunger centers Improving insulin secretion while suppressing glucagon release Creating a caloric deficit through reduced food intake Originally developed for type 2 diabetes management, these medications have gained FDA approval for chronic weight management in adults with obesity or overweight with weight-related comorbidities
The highest monotherapy dose studied is 4.5 mg per week (Lancet 2021 Phase 2)
Troys focus on individualised care ensures that patients not only get the most out of their semaglutide GLP-1 treatment but also have the tools and knowledge needed to achieve sustainable, long-term weight loss success